🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔬 Discover what’s possible with 3D human tissue models. From disease modeling to toxicity screening, see how organ-on-a-chip tech is advancing research. Explore real-world data, ready-to-use protocols & use cases across drug discovery & beyond: shorturl.at/tVpAy

🔬 NAMs are no longer “next”—they’re now. A new perspective highlights growing regulatory momentum behind NAMs & MPS in drug safety. At MIMETAS, we’re proud to help drive this shift. 🧠 Read more: doi.org/10.1093/toxsci… 💬 What’s the biggest enabler—or barrier?

🎓 Huge congrats to Dr. Haley Ehlers on defending her PhD at Leiden University! Her work at MIMETAS was on developing healthy and diseased artery-on-a-chip models for vascular research. Read her thesis: lnkd.in/eXfDQ3tY #PhDDefense #OrganOnAChip #WomenInSTEM

🎓 Congrats to Dr. Flavio Bonanini on his PhD defense! His work at MIMETAS on liver MPS brings us closer to better, animal-free drug testing for diseases like diabetes & liver fibrosis. 🧪🩺 Watch his webinar: lnkd.in/eqdEFYaP #PhDDefense #LiverOnAChip #MPS

Researchers in preclinical toxicology—don’t miss this. Our latest webinar on 3D in vitro models for assessing new drug modalities is now available on demand. Learn how organ-on-a-chip tech is advancing predictive toxicology with real human relevance. shorturl.at/caHUN

The FDA is phasing out animal testing for therapies like monoclonal antibodies, pushing for human-relevant “NAMs” like organ-on-a-chip, AI toxicity models & human cell assays. A huge shift we’ve long championed at MIMETAS. 🔗Read the announcement: fda.gov/news-events/pr…

💡 How can we make drug discovery more human-relevant? MIMETAS CTO Dr. Bas Trietsch shares how MPS and our UniFlow tech are enabling scalable, predictive drug screening using realistic tissue models. 🔗 Full interview: technologynetworks.com/drug-discovery… #DrugDiscovery #MPS

80% of immunology drugs fail before reaching patients. Why? Most models can’t reflect the complexity of the human immune system. Explore how 3D tissue models are closing the translational gap in our latest whitepaper. shorturl.at/c9GpW #Immunology #OrganOnAChip

#AACR2025 has kicked off! Meet the MIMETAS team at Booth 2741 & learn about our 3D human disease models for oncology research and drug discovery. Connect with Remko, Karla, and Nick onsite! Full schedule below 👇mimetas.com/en/events/887/… #LifeSciences #3DCellCulture #OrganOnAChip

Today at #AACR2025: Our collaborators at CCRI present new cancer research using the OrganoPlate®. 🗓️ April 29 | 9–12 📍 Tumor Biology | PO.TB09.03 🎙️ EWS::FLI1 & Tumor Plasticity in Ewing Sarcoma Presented by Veveeyan Suresh! mimetas.com/en/cancer-drug… #CancerResearch

Final day at #AACR2025! Visit Booth 2741 to meet the MIMETAS team and learn how we can support your cancer research. Check out our 4 posters: 🧬 Liver fibrosis & gene delivery 🧠 GBM-vasculature 🧫 HCC microenvironment 🧪 CAR-T co-culture Download posters: mimetas.com/en/posters/

New publication on an artery-on-a-chip model with unidirectional, gravity-driven flow using Uniflow™ tech. This model opens new doors for drug development, vascular inflammation studies, and cardiovascular research. 🔗shorturl.at/t0Woj 🔍shorturl.at/OhRiw

Cancer kills 10M+ yearly, but <5% of oncology drugs succeed. Why? Poor preclinical models. 📅 Join our webinar on May 13 to explore how 3D tumor models + OrganoPlate® platform are transforming cancer drug discovery. 🔗 shorturl.at/t7yyS #CancerResearch #Webinar

⏳ Only 1 day left to register! Join us tomorrow (May 13) for a live webinar with Dr. Karla Queiroz on breakthrough 3D tumor models that are transforming oncology R&D. Learn how we enable predictive, human-relevant cancer research. 🔗 Sign up now: shorturl.at/JBRh0

🧠 How does glioblastoma disrupt the blood-brain barrier? Our new poster shows how vascularized GBM-on-a-chip models + patient-derived spheroids reveal key tumor-vascular interactions: shorturl.at/GIPHB 🔗Explore our Cancer Services shorturl.at/FNEkv

Watch real-time unidirectional perfusion as fluorescent beads flow through a self-assembled 3D microvascular network. Achieved using Uniflow Technology —gravity-driven flow that supports accurate human tissue models. 🔗 Learn more: shorturl.at/yYlbc

We’re heading to #MPS2025 in Brussels! 🧬 📍 Booth 416 | 🗓 June 9–13 Catch MIMETAS talks on vasculature & liver fibrosis + posters on colon, HCC, CAR-T & kidney models. Let’s connect! Details 👉 mimetas.com/en/events/894/… #OrganOnAChip #BiotechInnovation

GI toxicity is a major hurdle in drug development—especially for oncology. Our app note shows how the OrganoReady® Colon Organoid helps predict these effects using a human-relevant 3D model + multiplex assays. 🔗 shorturl.at/qWzje #GIToxicity #Organoids #Toxicology

⏰4 days until our live webinar: Learn how MIMETAS’ 3D kidney models are transforming CKD research. Explore immune-integrated models, real-world use cases, and a kidney-on-a-chip case study. Register for free: shorturl.at/W5muj #NAMs #KidneyResearch #OrganOnAChip #Webinar